Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells

Germline mutations in the tumor-suppressor gene BRCA2 predispose to breast and ovarian cancer. BRCA2 plays a well-established role in maintaining genome stability by regulating homologous recombination. BRCA2 has more recently been implicated in cytokinesis, the final step of cell division, but the molecular basis for this remains unknown. We have used time-lapse microscopy, recently developed cytokinesis assays and BAC recombineering (bacterial artificial chromosome recombinogenic engineering) to investigate the function and localization of BRCA2 during cell division. Our analysis suggests that BRCA2 does not regulate cytokinesis in human cells. Thus, cytokinesis defects are unlikely to contribute to chromosomal instability and tumorigenesis in BRCA2-related cancers.

[1]  D. Gerlich,et al.  Cytokinetic abscission: cellular dynamics at the midbody. , 2009, Trends in cell biology.

[2]  H. Tanke,et al.  BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[3]  D. Gerlich,et al.  Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization , 2009, Cell.

[4]  S. Sharan,et al.  Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2 , 2008, Nature Medicine.

[5]  M. Gorospe,et al.  A syngeneic variance library for functional annotation of human variation: application to BRCA2. , 2008, Cancer research.

[6]  Karl Mechtler,et al.  BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals , 2008, Nature Methods.

[7]  S C West,et al.  BRCA2: a universal recombinase regulator , 2007, Oncogene.

[8]  F. Barr,et al.  Cytokinesis: Placing and Making the Final Cut , 2007, Cell.

[9]  Neil J Ganem,et al.  Tetraploidy, aneuploidy and cancer. , 2007, Current opinion in genetics & development.

[10]  J. Peters,et al.  The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1 , 2007, Current Biology.

[11]  A. Venkitaraman,et al.  Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2 , 2004, Science.

[12]  Timothy J Mitchison,et al.  Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II Inhibitor , 2003, Science.

[13]  Derek Davies,et al.  BRCA2-dependent and independent formation of RAD51 nuclear foci , 2003, Oncogene.

[14]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[15]  S. West,et al.  Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. , 2000, Genes & development.

[16]  A. Ashworth,et al.  Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification , 1999, Current Biology.

[17]  G. Eichele,et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.

[18]  C. Moskaluk,et al.  Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.